Chapter 9: Personalized, Precise Treatments
By Stephanie Vine, Rob Coker
July 24, 2025
Experts give their views on why the potential future offered by personalized medicine is so exciting.
False
Advertisement
Future of Pharma
AbbVie’s Eleni Lagkadinou on the Future of Cancer
By Stephanie Vine
July 14, 2025
What comes next for cancer drug development? AbbVie’s Eleni Lagkadinou discusses precision, AI, and her hope for turning cancer into a more chronic, manageable condition.
11 min read
Facilities & Equipment
Technology & Manufacturing
Cell & Gene
Small Molecules
Blogs
Future of Pharma
Appreciating Academic Spinouts
By Rob Coker
May 14, 2025
Let us not forget the important role of academic spinouts in innovating across the modalities.
3 min read
Inhalable Gene Therapies? Here’s How They Could Work
By Stephanie Vine
May 1, 2025
Scientists explain how inhalable gene therapies are being developed to treat cystic fibrosis.
5 min read
Predictions for Pharma’s Future
April 8, 2025
We asked experts about their views of the future of pharma. Process digitization, data, and sustainability are key themes.
4 min read
AI, Big Data, and Digital Disruption
By Rob Ellison
March 31, 2025
An industry survey looks at changing attitudes and challenges in digital innovation for clinical research. Uptake is slow but steady.
7 min read
The Glycomic Revolution
March 27, 2025
Why the ability to design therapeutics based on glycobiology will make a mark on pharma R&D
2 min read
Looking to Next-Generation Sequencing and Multi Omics Technologies
March 17, 2025
Experts explain why these are two important areas to watch in the near future of pharma R&D.
2 min read
A Shared Vision for Global Health
February 20, 2025
Not all patients are able to reap the benefits of groundbreaking new therapeutics. Experts from Abzena and Genentech explain why there is a “collective responsibility across our industry to work toward a shared vision for health equity.”
2 min read
Trends and Therapeutic Areas to Watch in 2025
January 10, 2025
Personalized medicine, digital therapeutics, and GLP-1s; experts tell us what areas are hot in pharma’s future.
4 min read
